🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
VENTANA is a "window-of-opportunity" trial that will explore whether, simil...
Status
Completed
Location
Hospital Universitari Vall d'Hebron
Start Date
2016-07
Trial ID
NCT02802748
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
Triple-negative breast cancer (TNBC) is among the most aggressive and letha...
Status
Recruiting
Location
Fondazione IRCCS San Gerardo Dei Tintori
Start Date
2025-03-06
Trial ID
NCT06690840
Treatments Being Tested
Development of an active second-line treatment option for metastatic breast...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-25
Trial ID
NCT04143906
Treatments Being Tested
This is a phase II trial of Doxil on day 1 and vinorelbine on days 1 and 2 ...
Status
Unknown
Location
Hematology Oncology Consultants, Inc
Start Date
2003-10
Trial ID
NCT00159094
Treatments Being Tested
This study is an open label randomized multi-centre phase II trial in patie...
Status
Completed
Location
Department of Oncology, Aalborg University Hospital
Start Date
2009-05-01
Trial ID
NCT00887783
This study is a single-center, single-arm, prospective phase II clinical st...
Status
Completed
Location
Tianjin Cancer Hospital
Start Date
2021-01-01
Trial ID
NCT04903652
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as capecitabine and vinorelbine...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2004-08
Trial ID
NCT00093808
Treatments Being Tested
A phase II study to assess the efficacy and safety of Surufatinib or Surufa...
Status
Active Not Recruiting
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2020-06-03
Trial ID
NCT04922658
Treatments Being Tested
An open-label, single institutional phase II trial of losartan in patients ...
Status
Unknown
Location
Oslo University Hospital
Start Date
2019-10-01
Trial ID
NCT03951142
Treatments Being Tested